- Report
- March 2026
- 147 Pages
Global
From €3555EUR$3,999USD£3,085GBP
- Report
- October 2025
- 150 Pages
Global
From €5289EUR$5,950USD£4,590GBP
- Report
- January 2026
- 187 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- January 2026
- 199 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- May 2026
- 268 Pages
Global
From €5200EUR$5,850USD£4,513GBP
- Report
- May 2026
- 297 Pages
Global
From €5200EUR$5,850USD£4,513GBP
- Report
- May 2026
- 174 Pages
Global
From €5200EUR$5,850USD£4,513GBP
- Report
- May 2026
- 372 Pages
Global
From €5200EUR$5,850USD£4,513GBP
- Report
- May 2026
- 446 Pages
Global
From €5200EUR$5,850USD£4,513GBP
- Report
- March 2026
- 250 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- February 2026
- 250 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- February 2026
- 250 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- February 2026
- 250 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- February 2026
- 150 Pages
Global
From €3333EUR$3,750USD£2,893GBP
- Report
- February 2026
- 200 Pages
Global
From €4440EUR$4,995USD£3,853GBP
- Report
- April 2026
- 112 Pages
Global
From €3500EUR$4,218USD£3,144GBP
- Report
- April 2026
- 128 Pages
Global
From €3500EUR$4,218USD£3,144GBP
- Report
- February 2026
- 187 Pages
Global
From €4311EUR$4,850USD£3,741GBP
- Report
- January 2026
- 200 Pages
Global
From €4311EUR$4,850USD£3,741GBP
- Report
- November 2025
- 150 Pages
Global
From €4311EUR$4,850USD£3,741GBP

The Bioprosthetic Valve market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to replace or repair a patient's heart valve. These valves are made from animal tissue, such as porcine or bovine, and are designed to mimic the natural functioning of the human heart valve. Bioprosthetic valves are used to treat a variety of conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation. They are also used in combination with other treatments, such as coronary artery bypass grafting.
Bioprosthetic valves are becoming increasingly popular due to their durability and low risk of complications. They are also cost-effective and require less maintenance than mechanical valves.
Some of the major companies in the Bioprosthetic Valve market include Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, and Sorin Group. Show Less Read more